KLOW

KLOW

KLOW is a named research blend of GHK-Cu, KPV, BPC-157, and a thymosin beta-4 fragment (TB-4 / TB-500), listed under the supplier name. It is not an adiponectin peptide. This listing is for laboratory research use only. It is not a drug, food, cosmetic, or dietary supplement, and it is not approved for human or veterinary use.

Research Context

The four components appear separately in the scientific literature. The blend is a catalog combination of a copper-binding tripeptide, the C-terminal α-MSH tripeptide KPV, a gastric pentadecapeptide fragment, and a thymosin β4 fragment. This page does not describe administration, dosing, or personal use.

Research Overview

Laboratory work on the components has examined copper-peptide, melanocortin-fragment, matrix, and actin-cytoskeleton assays in controlled experimental systems. Findings from those models are not established as safe or effective for people or animals, and nothing here is medical advice.

Key Research Focus Areas

• Four-component identity: GHK-Cu, KPV, BPC-157, and thymosin β4 fragment
• Copper-tripeptide and matrix-biology laboratory models
• α-MSH C-terminal tripeptide (KPV) inflammatory-signaling assays
• Actin-cytoskeleton and pentadecapeptide tissue-model work
• Analytical identity of a named research blend

Important Disclaimer

For research use only. Not for human or veterinary use. Not intended to diagnose, treat, cure, or prevent any disease. Not medical advice. Handle only in a qualified research setting and in compliance with applicable law.